Liver Transplantation for Alcoholic Hepatitis: Standard of Care Yet?

Abstract

Alcohol-related liver disease (ALD) is one of the most common indications for liver transplantation. However, liver transplantation for alcoholic hepatitis (AH) remains controversial. The morbidity of severe alcoholic hepatitis (SAH) is extremely high, with most of the deaths occurring within the first 2 months. Multiple studies have recently demonstrated significant improvement in overall survival following liver transplantation in patients with SAH who failed medical management, with comparable rates to those transplanted electively. Concerns remain due to the small pool of donors and the high risk of alcohol relapse in this population. The traditional requirement of 6 months of abstinence prior to transplantation, or also known as “6-month rule” is controversial and has been criticized as whether it is a good predictor of long-term sobriety. Previous studies among patients with alcoholic cirrhosis have indicated that this rule poorly identifies patients who will relapse after liver transplantation. More recent studies in patients transplanted for SAH, have reported relapse rates that are comparable to those with abstinence periods >6 months. Applying stringent selection criteria appears to be key in identifying patients who are less likely to relapse after transplantation, and therefore prolonging patient and graft life. However, further research is needed to identify patients at risk and create appropriate screening tools. In this article, we present a review of currently available data on this topic.

Keywords

liver transplantation - alcohol-related liver disease - review

• References

• 1 Mathurin P, Moreno C, Samuel D. , et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med 2011; 365 (19) 1790-1800
• 2 Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med 2009; 360 (26) 2758-2769
• 3 Schwartz JM, Reinus JF. Prevalence and natural history of alcoholic liver disease. Clin Liver Dis 2012; 16 (04) 659-666
• 4 Louvet A, Naveau S, Abdelnour M. , et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 2007; 45 (06) 1348-1354
• 5 Daswani R, Kumar A, Sharma P, Singla V, Bansal N, Arora A. Role of liver transplantation in severe alcoholic hepatitis. Clin Mol Hepatol 2018; 24 (01) 43-50
• 6 Papastergiou V, Tsochatzis EA, Pieri G. , et al. Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort. Aliment Pharmacol Ther 2014; 39 (07) 721-732
• 7 Maddrey WC, Boitnott JK, Bedine MS, Weber Jr FL, Mezey E, White Jr RI. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 75 (02) 193-199
• 8 Burra P, Senzolo M, Adam R. , et al; ELITA; ELTR Liver Transplant Centers Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry). Am J Transplant 2010; 10 (01) 138-148
• 9 Im GY, Kim-Schluger L, Shenoy A. , et al. Early liver transplantation for severe alcoholic hepatitis in the United States—a single-center experience. Am J Transplant 2016; 16 (03) 841-849
• 10 Lee BP, Chen PH, Haugen C. , et al. Three-year results of a pilot program in early liver transplantation for severe alcoholic hepatitis. Ann Surg 2017; 265 (01) 20-29
• 11 Mathurin P. Corticosteroids for alcoholic hepatitis—what's next?. J Hepatol 2005; 43 (03) 526-533
• 12 Testino G, Burra P, Bonino F. , et al; Group of Italian Regions Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: an Italian position statement. World J Gastroenterol 2014; 20 (40) 14642-14651
• 13 Beresford TP, Everson GT. Liver transplantation for alcoholic liver disease: bias, beliefs, 6-month rule, and relapse—but where are the data?. Liver Transpl 2000; 6 (06) 777-778
• 14 DiMartini A, Day N, Dew MA. , et al. Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl 2006; 12 (05) 813-820
• 15 Foster PF, Fabrega F, Karademir S, Sankary HN, Mital D, Williams JW. Prediction of abstinence from ethanol in alcoholic recipients following liver transplantation. Hepatology 1997; 25 (06) 1469-1477
• 16 Marot A, Dubois M, Trépo E, Moreno C, Deltenre P. Liver transplantation for alcoholic hepatitis: a systematic review with meta-analysis. PLoS One 2018; 13 (01) e0190823
• 17 Dew MA, DiMartini AF, Steel J. , et al. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl 2008; 14 (02) 159-172
• 18 De Gottardi A, Spahr L, Gelez P. , et al. A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years. Arch Intern Med 2007; 167 (11) 1183-1188
• 19 Altamirano J, López-Pelayo H, Michelena J. , et al. Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: prediction and impact on long-term survival. Hepatology 2017; 66 (06) 1842-1853
• 20 Trafficking O. The declaration of Istanbul on organ trafficking and transplant tourism. Istanbul Summit April 30-May 2, 2008. Nephrol Dial Transplant 2008; 23 (11) 3375-3380
• 21 Donckier V, Lucidi V, Gustot T, Moreno C. Ethical considerations regarding early liver transplantation in patients with severe alcoholic hepatitis not responding to medical therapy. J Hepatol 2014; 60 (04) 866-871
• 22 Stroh G, Rosell T, Dong F, Forster J. Early liver transplantation for patients with acute alcoholic hepatitis: public views and the effects on organ donation. Am J Transplant 2015; 15 (06) 1598-1604
• 23 Asrani SK, Trotter J, Lake J. , et al. Meeting report: the Dallas consensus conference on liver transplantation for alcohol associated hepatitis. Liver Transpl 2020; 26 (01) 127-140